tiprankstipranks
Advertisement
Advertisement
S&P 600 adding fifteen companies at open on 3/23
PremiumThe FlyS&P 600 adding fifteen companies at open on 3/23
2M ago
Myriad Genetics Earnings Call Highlights Growth Amid Headwinds
Premium
Company Announcements
Myriad Genetics Earnings Call Highlights Growth Amid Headwinds
2M ago
Myriad Genetics files $200M mixed securities shelf
Premium
The Fly
Myriad Genetics files $200M mixed securities shelf
3M ago
Balancing Emerging Growth Momentum and Ongoing Uncertainty: Justifying a Hold Amid Attractive Valuation
PremiumRatingsBalancing Emerging Growth Momentum and Ongoing Uncertainty: Justifying a Hold Amid Attractive Valuation
3M ago
Myriad Genetics sees Q1 revenue $200M-$203M, consensus $211.19M
Premium
The Fly
Myriad Genetics sees Q1 revenue $200M-$203M, consensus $211.19M
3M ago
Myriad Genetics backs FY26 revenue view $860M-$880M, consensus $868.06M
Premium
The Fly
Myriad Genetics backs FY26 revenue view $860M-$880M, consensus $868.06M
3M ago
Myriad Genetics advances MRD commercialization timeline
PremiumThe FlyMyriad Genetics advances MRD commercialization timeline
4M ago
Myriad Genetics sees Q4 revenue $207M-$209M, consensus $207.1M
Premium
The Fly
Myriad Genetics sees Q4 revenue $207M-$209M, consensus $207.1M
4M ago
Myriad Genetics sees FY26 revenue $860M-$880M, consensus $869.3M
Premium
The Fly
Myriad Genetics sees FY26 revenue $860M-$880M, consensus $869.3M
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100